Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Extract
Bronchiectasis is a chronic inflammatory disease [1, 2]. Although it is recognised that bronchiectasis is composed of multiple phenotypes and endotypes, inflammation has classically been regarded as neutrophilic and patients with higher levels of neutrophilic inflammation have been shown to have worse clinical outcomes [3–5].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Aliberti, S., Ringshausen, F. C., Dhar, R., Haworth, C. S., Loebinger, M. R., Dimakou, K., Crichton, M. L., De Soyza, A., Vendrell, M., Burgel, P.-R., McDonnell, M., Skrgat, S., Maiz Carro, L., de Roux, A., Sibila, O., Bossios, A., van der Eerden, M., Kau Tags: CF and non-CF bronchiectasis Original Articles: Bronchiectasis Source Type: research
More News: Respiratory Medicine